Remed Co.Ltd (302550) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.006x

Based on the latest financial reports, Remed Co.Ltd (302550) has a cash flow conversion efficiency ratio of 0.006x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩238.69 Million ≈ $161.76K USD) by net assets (₩39.24 Billion ≈ $26.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 302550 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Remed Co.Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Remed Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Remed Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Remed Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mercor S.A. WAR:MCR	-0.262x
Gedeon Richter PLC LSE:0QFP	0.038x
ktcs corporation KO:058850	-0.054x
iBio, Inc. Common Stock NASDAQ:IBIO	-0.093x
Export Packing KO:002200	0.002x
Haulotte Group SA PA:PIG	0.029x
Newbridge Acquisition Limited Class A Ordinary Share NASDAQ:NBRG	0.115x
Skane mollan AB ST:SKMO	0.022x

Annual Cash Flow Conversion Efficiency for Remed Co.Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Remed Co.Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Remed Co.Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩39.46 Billion ≈ $26.74 Million	₩2.40 Billion ≈ $1.62 Million	0.061x	+96.37%
2024-12-31	₩40.25 Billion ≈ $27.28 Million	₩1.24 Billion ≈ $843.40K	0.031x	-72.79%
2023-12-31	₩30.79 Billion ≈ $20.87 Million	₩3.50 Billion ≈ $2.37 Million	0.114x	-34.77%
2022-12-31	₩29.92 Billion ≈ $20.28 Million	₩5.21 Billion ≈ $3.53 Million	0.174x	+230.28%
2021-12-31	₩26.10 Billion ≈ $17.69 Million	₩-3.49 Billion ≈ $-2.36 Million	-0.134x	-227.93%
2020-12-31	₩24.79 Billion ≈ $16.80 Million	₩2.59 Billion ≈ $1.76 Million	0.105x	-20.14%
2019-12-31	₩24.62 Billion ≈ $16.69 Million	₩3.22 Billion ≈ $2.18 Million	0.131x	+550.48%
2018-12-31	₩10.94 Billion ≈ $7.42 Million	₩-317.96 Million ≈ $-215.48K	-0.029x	-282.16%
2017-12-31	₩4.19 Billion ≈ $2.84 Million	₩66.75 Million ≈ $45.24K	0.016x	--

About Remed Co.Ltd

KQ:302550 Korea Medical Devices

Market Cap

$61.04 Million

₩90.07 Billion KRW

Market Cap Rank

#21180 Global

#1211 in Korea

Share Price

₩2975.00

Change (1 day)

+0.17%

52-Week Range

₩2660.00 - ₩3985.00

All Time High

₩4180.00